Paper26323474
GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy.
Sawicka-Gutaj N and 7 others. Endokrynol Pol, 2015. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. GO-QOL--disease-specific quality of life questionnaire in Graves' orbitopathy. Papers, record 26323474. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26323474
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Graves Ophthalmopathy | Major topic |
| Quality of Life | Major topic |
| Surveys and Questionnaires | Major topic |
| Translations | Major topic |
| Humans | |
| Poland |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06367517 | Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease) | Background |
Source ClinicalTrials.gov
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39592974 | Tocilizumab for the management of corticosteroid-resistant GO combined with OMG: a case series. | BMC Ophthalmol | 2024 | https://conductscience.org/library/papers/39592974 | PubMed |
| 36346683 | Measuring Health-Related Quality of Life in Thyroid Eye Disease. | J Clin Endocrinol Metab | 2022 | https://conductscience.org/library/papers/36346683 | PubMed |
| 33511081 | Proposal for Standardization of Primary and Secondary Outcomes in Patients with Active, Moderate-to-Severe Graves' Orbitopathy. | Eur Thyroid J | 2020 | https://conductscience.org/library/papers/33511081 | PubMed |
| 30621642 | Severe unilateral orbitopathy in a patient with Hashimoto's thyroiditis - a case report. | BMC Ophthalmol | 2019 | https://conductscience.org/library/papers/30621642 | PubMed |
| 29675428 | PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/29675428 | PubMed |
| 29546048 | Changes of Nicotinamide Phosphoribosyltransferase Expressions in Thyroid Glands of Patients with Different Thyroid Pathologies. | Biomed Res Int | 2018 | https://conductscience.org/library/papers/29546048 | PubMed |
| 27829681 | Gender-dependent and age-of-onset-specific association of the rs11675434 single-nucleotide polymorphism near TPO with susceptibility to Graves' ophthalmopathy. | J Hum Genet | 2017 | https://conductscience.org/library/papers/27829681 | PubMed |
| 26767650 | Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves' opthalmopathy. | Endocrine | 2016 | https://conductscience.org/library/papers/26767650 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26323474
GET https://conductscience.org/api/papers/v1/26323474/authors